These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 27622611

  • 1. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
    Kim JC, Cho KJ, Lee JG, Seo JT, Kim DY, Oh SJ, Lee KS, Choo MS, Lee JZ.
    J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611
    [Abstract] [Full Text] [Related]

  • 2. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
    Bae WJ, Bae JH, Kim SW, Chung BH, Kim JH, Kim CS, Lee HM, Lee KS, Yoo TK, Kim SI, Byun SS, Lee JY.
    J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
    [Abstract] [Full Text] [Related]

  • 3. Desmopressin for treating nocturia in men.
    Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P.
    Cochrane Database Syst Rev; 2017 Oct 21; 10(10):CD012059. PubMed ID: 29055129
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK, Dmochowski RR, Reddy J, van der Meulen EA.
    J Urol; 2013 Sep 21; 190(3):958-64. PubMed ID: 23454404
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP, Herschorn S, Albei CD, van der Meulen EA.
    J Urol; 2013 Sep 21; 190(3):965-72. PubMed ID: 23454402
    [Abstract] [Full Text] [Related]

  • 6. Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
    Berges R, Höfner K, Gedamke M, Oelke M.
    World J Urol; 2014 Oct 21; 32(5):1163-70. PubMed ID: 25135845
    [Abstract] [Full Text] [Related]

  • 7. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice.
    Chen SL, Huang YH, Hung TW, Ou YC.
    Int J Clin Pract; 2016 May 21; 70(5):372-9. PubMed ID: 27039892
    [Abstract] [Full Text] [Related]

  • 8. Twelve-week, prospective, open-label, randomized trial on the effects of an anticholinergic agent or antidiuretic agent as add-on therapy to an alpha-blocker for lower urinary tract symptoms.
    Shin YS, Zhang LT, Zhao C, Kim YG, Park JK.
    Clin Interv Aging; 2014 May 21; 9():1021-30. PubMed ID: 25031529
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development program.
    Yamaguchi O, Juul KV, Falahati A, Yoshimura T, Imura F, Kitamura M.
    Low Urin Tract Symptoms; 2020 Jan 21; 12(1):8-19. PubMed ID: 31397969
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Desmopressin to Treat Nocturnal Polyuria in Elderly Men: Effects on Sleep Quality.
    Kim SO, Yu HS, Kwon D.
    Urol Int; 2016 Jan 21; 96(4):438-42. PubMed ID: 26836495
    [Abstract] [Full Text] [Related]

  • 11. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES, Raymond K, Andruczyk E, Juul KV.
    Low Urin Tract Symptoms; 2018 Sep 21; 10(3):221-230. PubMed ID: 28560762
    [Abstract] [Full Text] [Related]

  • 12. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study.
    Wang CJ, Lin YN, Huang SW, Chang CH.
    J Urol; 2011 Jan 21; 185(1):219-23. PubMed ID: 21074790
    [Abstract] [Full Text] [Related]

  • 13. Desmopressin for treating nocturia in men.
    Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P.
    BJU Int; 2018 Oct 21; 122(4):549-559. PubMed ID: 29489052
    [Abstract] [Full Text] [Related]

  • 14. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP.
    Eur Urol; 2007 Jul 21; 52(1):221-9. PubMed ID: 17280773
    [Abstract] [Full Text] [Related]

  • 15. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP, Zinner NR, Klein BM, Nørgaard JP.
    Neurourol Urodyn; 2012 Apr 21; 31(4):441-7. PubMed ID: 22447415
    [Abstract] [Full Text] [Related]

  • 16. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O, Nishizawa O, Juul KV, Nørgaard JP.
    BJU Int; 2013 Mar 21; 111(3):474-84. PubMed ID: 23046147
    [Abstract] [Full Text] [Related]

  • 17. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA, Roehrborn CG, Gong J, Sun F, Guan Z.
    BJU Int; 2012 Jun 21; 109(12):1831-40. PubMed ID: 21966995
    [Abstract] [Full Text] [Related]

  • 18. [INITIAL TREATMENT OF NOCTURIA CAUSED BY NOCTURNAL POLYURIA WITH LOW-DOSE DESMOPRESSIN].
    Hayashi K, Fuji K, Omizu M, Hiramatsu A, Koizumi S, Matsubara E, Saito K, Yamagishi M, Sasaki H, Fukagai T, Ishikawa K, Ogawa Y.
    Nihon Hinyokika Gakkai Zasshi; 2021 Jun 21; 112(1):18-24. PubMed ID: 35046231
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials.
    Kaminetsky J, Fein S, Dmochowski R, MacDiarmid S, Abrams S, Cheng M, Wein A.
    J Urol; 2018 Sep 21; 200(3):604-611. PubMed ID: 29654805
    [Abstract] [Full Text] [Related]

  • 20. Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity.
    Lee HW, Choo MS, Lee JG, Park CH, Paick JS, Lee JZ, Han DH, Park WH, Lee KS.
    J Korean Med Sci; 2010 Dec 21; 25(12):1792-7. PubMed ID: 21165296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.